Ozempic® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. View Limitations of Use.
See the efficacy data from the Ozempic® clinical trial program
CVOT=cardiovascular outcomes trial.
aThe primary composite endpoint was the time from randomization to first occurrence of a MACE: CV death, nonfatal myocardial infarction, or nonfatal stroke. Results apply to Ozempic® plus standard of care alone in SUSTAIN 6 trial.
What could your patients who make the change to Ozempic® expect?
bData from VANTAGE Fingertip Formulary bridge/April 2019 Nomenclature, and Xponent PlanTrak using week ending 05/03/2019; only considers bridged volume; excludes cash and mail order data.
cApplies to eligible, commercially insured patients with coverage for Ozempic®; eligibility and restrictions apply.
dEligible commercially insured patients pay as little as $25. Savings card covers up to $150 per prescription.
eCommercially insured patients only with coverage for Ozempic®. Maximum savings of up to $150. Offer only good at participating pharmacies in RelayHealth network.
- Ozempic [package insert]. Plainsboro, NJ: Novo Nordisk Inc; December 2017.